|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 1850874 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06735838.2 |
| Date of filing the European patent application | 2006-02-21 | |
| (97) | Date of publication of the European application | 2007-11-07 |
| (45) | Date of publication and mention of the grant of the patent | 2013-10-16 |
| (46) | Date of publication of the claims translation | 2014-01-27 |
| (86) | Number | PCT/US2006/006334 |
| Date | 2006-02-21 |
| (87) | Number | WO 2006/091693 |
| Date | 2006-08-31 |
| (30) | Number | Date | Country code |
| 655277 P | 2005-02-23 | US |
| (72) |
DERYNCK, Mika K., US
KELSEY, Stephen M., US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080-4990,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Ligos progresavimo arba išgyvenimo laiko prailginimas kiaušidžių vėžių sergančios pacientės, vartojančios pertuzumabą |
| EXTENDING TIME TO DISEASE PROGRESSION OR SURVIVAL IN OVARIAN CANCER PATIENTS USING PERTUZUMAB |
| Payment date | Validity (years) | Amount | |
| 2016-02-02 | 11 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2016-04-18 |